Review Article

The Association of New-Onset Atrial Fibrillation and Risk of Cancer: A Systematic Review and Meta-Analysis

Table 2

Patient characteristics of the five studies.

StudyAge (years)Sex (M/F %)HypertensionHyperlipidemiaDiabetesDefinitionIncident casesTypes of cancer
NOAFN-NOAFNOAFN-NOAFNOAFN-NOAFNOAFN-NOAFNOAFN-NOAFNOAFCANOAFSub-CA

Conen 2016 [9]58.0 (52.0–64.0)53 (49–58)FemaleNA6108550501998864870ECG or med reportPathology/cytology reports1467147Colon/breast cancer
Wassertheil 2017 [10]66.9 ± 7.163.2 ± 7.3FemaleNA201125716905116123253199ECG or self-reportMedical diagnosis during the follow-up4,376198Colorectal/breast cancer
Hung 2018 [11]74 ± 13.6NA53.6/46.4NA3477NA864NA2981NAICD-9ICD-95130330Colon/breast/liver/lung cancer
Saliba 2018 [12]63.6 ± 13.664.3 ± 13.623.6/76.4NA416448683196399018202147ECGPathology/cytology reports890352Colorectal/breast cancer
Vinter 2018 [13]56.2 (52.7–60.4)NA47.6/52.4NANANANANANANAICD-8/10 or med reportICD-102776533Prostate/lung/colorectal/breast cancer
Hung 2019 [14]70.8 ± 13.1NA55.2/44.8NA227956NA83207NA94515NAICD-9ICD-93325552291110 kinds of specific cancers

NOAF, new-onset atrial fibrillation; N-NOAF, not new-onset atrial fibrillation; Sub-CA, subsequent cancer; NA, not applicable; ECG, electrocardiography; ICD, International Classification of Diseases; Med, medicine.